CHOP

NRG Energy celebrates $4 million donation milestone to Children’s Hospital of Philadelphia, thanks to its Choose to Give program

Retrieved on: 
Giovedì, Maggio 9, 2024
Managed Care, Other Health, General Health, Other Energy, Utilities, Philanthropy, Oil, Gas, Energy, Hospitals, Fund Raising, Foundation, Other Philanthropy, Health, Learning, MSN, Pulmonary hypertension, Hospital, NRG, CHOP, Communication, Electricity, Growth, Research, FACC, Cardiology, CCRN, Patient, Child, RN, Medulla oblongata, Multimedia, NRG Energy, Division

The milestone was celebrated at the hospital with a check presentation and a tour of the Cardiac Center at CHOP.

Key Points: 
  • The milestone was celebrated at the hospital with a check presentation and a tour of the Cardiac Center at CHOP.
  • To date, NRG has contributed more than $4.2 million through the program, funding more than 30 projects and research initiatives led by experts in CHOP’s Cardiac Center.
  • When NRG customers enroll through the Choose to Give electricity plan, NRG contributes $50 to CHOP.
  • To date, NRG and its customers have contributed more than $15 million to local organizations across the country through this program.

CHOP and NJ HTS Launch New Website Dedicated to Promoting Traffic Safety

Retrieved on: 
Martedì, Maggio 7, 2024
Rail transport by country, Information technology, Transport, Hospital, Safety, CHOP, Research, Collection, Doctor of Philosophy, CIRP, HTS, Department of motor vehicles, Fatality, Crash, Death, Children's Hospital of Philadelphia, Pedestrian

PHILADELPHIA, May 7, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP)'s New Jersey Safety and Health Outcomes (NJ-SHO) Center for Integrated Data and the New Jersey Division of Highway Traffic Safety (HTS) are pleased to announce the launch of njsho.chop.edu, a website that features an interactive data dashboard that enables users to visualize, monitor, and track important traffic safety measures across communities and over time.

Key Points: 
  • The NJ-SHO Center for Integrated Data team is reimagining how data are collected, integrated, analyzed, and shared to support safe transport in New Jersey.
  • The data dashboard offers access to previously unavailable data to guide and evaluate local and statewide solutions for reducing the burden of injury and deaths.
  • The website also shares evidence-based injury prevention, transportation equity, and traffic safety resources to help drive positive change throughout the state.
  • "We hope that regional, local, and community partners will use our dashboard to implement safety efforts that ultimately move the needle on reducing crashes."

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

Retrieved on: 
Giovedì, Maggio 2, 2024
Biotechnology, Professional Services, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Science, Clinical Trials, Finance, Doctor of Philosophy, CNS, SVP, Translational medicine, MIT, Genzyme, Cochlea, Hereditary Disease Foundation, Harvard Medical School, Toxicity, HTT, Therapy, Merck, CLN2, Hospital, Safety, Biomedical Research, Samsung Biologics, CHOP, Samsung C&T Corporation, AAV, Koch Institute, Gene expression, Central nervous system, NHP, Program management, Cell, DSM-IV codes, Patient, Gene, Society, Einstein Medical Center Philadelphia, Annual general meeting, Massachusetts General Hospital, Pharmaceutical industry

Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.

Key Points: 
  • Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.
  • These limitations have led to the reliance on high-dose injections that cause off-target toxicity and difficulties in scalable manufacturing.
  • The Company’s management team is composed of experienced and respected leaders in gene therapy and neuroscience.
  • Her address will showcase the Company's progress and the vast potential of its technology to solve unmet needs in CNS gene therapy.

CHOP Study Finds Healthcare Providers Play Crucial Role in Guiding Autistic Adolescents and Their Families into Adulthood

Retrieved on: 
Lunedì, Aprile 29, 2024
Online, Bangladesh Technical Education Board, Spectrum, Learning, Hospital, CHOP, Research, DSM-IV codes, Health care, Doctor of Philosophy, Transport, CIRP, Licensure, Child, Caregiver, Children's Hospital of Philadelphia, Quality of life, Journal, Nursing

The study also highlighted the crucial role of healthcare providers in fostering collaborative decision-making around key milestones for adulthood, along with support strategies to help families assess driving readiness.

Key Points: 
  • The study also highlighted the crucial role of healthcare providers in fostering collaborative decision-making around key milestones for adulthood, along with support strategies to help families assess driving readiness.
  • Healthcare providers are eager to improve quality of life for autistic adolescents by acting as facilitators during this transitional time.
  • Providers recognized that working towards independence can offer significant benefits for autistic youths and their families.
  • Preparing to "Live a Life of Possibilities": Experiences of Healthcare Providers Readying Autistic Adolescents and Their Families for Independent Driving.

CHOP Researchers Discover Underlying Biology Behind Fontan-Associated Liver Disease

Retrieved on: 
Mercoledì, Aprile 24, 2024
Online, Science Publishing Group, Fontan procedure, Patient, Cell, Hepatocyte, Liver disease, Inferior vena cava, Science Translational Medicine, Hope, NIH, Hospital, Blood, Tissue, Robert, CHOP, Agent handling, Heart, Wellness, MD, RNA, Medical laboratory, Doctor of Philosophy, SVRF, Activity, Survivor, Disease, Pathology, Ventricular septal defect, Fibrosis, Stasi, FC, Assistant, Biology, Children's Hospital of Philadelphia, Quality of life, Scar, Defense, Pharmaceutical industry

PHILADELPHIA, April 24, 2024 /PRNewswire/ -- As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).

Key Points: 
  • In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).
  • The Fontan operation is the current standard of care for single-ventricle congenital heart disease.
  • As more patients undergo the Fontan surgery for single-ventricle congenital heart disease, FALD has become a more recognized problem.
  • Little information exists on FALD, yet it is distinct from other forms of liver disease, which is why researchers at CHOP wanted to understand the basic biology that could lead to better treatment options and improve these patients' quality of life.

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

Retrieved on: 
Martedì, Aprile 23, 2024
FDA, Lutetium (177Lu) oxodotreotide, Brain, Cancer, Prostate, RLT, Hospital, Food, CHOP, Breast, B cell, Somatostatin, Disease, Incidence, Patient, Lung, National Cancer Institute, Diagnosis, Children's Hospital of Philadelphia, NETS, Ageing, Pharmaceutical industry

This approval makes Lutathera the first therapy specifically reviewed and approved for use in pediatric patients with GEP-NETs.

Key Points: 
  • This approval makes Lutathera the first therapy specifically reviewed and approved for use in pediatric patients with GEP-NETs.
  • "Lutathera is now the very first therapy approved specifically for children with GEP-NETs, offering new hope to young patients living with this rare cancer," said Tina Deignan, Therapeutic Area Head, Oncology US.
  • NETs are a type of cancer that originates in neuroendocrine cells throughout the body and are commonly considered slow-growing malignancies1.
  • In addition, the estimated radiation absorbed dose in pediatric patients was within established organ thresholds for external beam radiation and comparable to that in adults for the approved dose.

In Celebration of National Volunteer Month, Children's Hospital of Philadelphia and The Wawa Foundation Announce Inaugural Helping Hands Community Care Challenge

Retrieved on: 
Martedì, Aprile 23, 2024
Volunteering, Coffee, Education, Pain, SNAP, Fear, Hope, Hospital, Housing, CHOP, LDS Family Services, National Volunteer Month, Patient, Adolescence, WIC, Family, Poverty, Therapy, Child, Assistant, Children's Hospital of Philadelphia, Anxiety, Drink, Organization

PHILADELPHIA, April 23, 2024 /PRNewswire/ -- To celebrate April as National Volunteer Month, Children's Hospital of Philadelphia (CHOP) and The Wawa Foundation, commemorating its 10th anniversary this year, have come together to announce the inaugural Helping Hands Community Care Challenge taking place on Friday, September 13. The day-long event will bring together hundreds of representatives from local companies who will participate in various volunteer programs benefiting patients and families at CHOP.

Key Points: 
  • Additionally, the well-known and beloved Wawa Coffee and Care Cart will be on-site serving attendees, sharing a marquee example of a volunteer activity at CHOP.
  • Funds raised through Helping Hands support Wawa Volunteer Services at CHOP, empowering the expansion and elevation of the volunteer program, engaging more community members and creating a ripple effect of kindness.
  • "We are thrilled to partner with CHOP to present the Helping Hands Community Care Challenge," said Maria Kalogredis, Chair of The Wawa Foundation.
  • To learn more about this inaugural event and how it will impact the community, go to helpinghands.chop.edu .

Citadel Credit Union Reinforces Commitment To The Communities It Serves Through Ongoing Initiatives Amid Continued Growth

Retrieved on: 
Martedì, Aprile 16, 2024
Citadel, Online, Daily Local News, Education, Credit union, CHOP, Local news, Annual report, Citadel Credit Union, Wellness, Partnership, VISTA, Retirement, FFD, Food security, Growth, Key, Online shopping

EXTON, Pa., April 16, 2024 /PRNewswire/ -- Citadel Credit Union is reinforcing its dedication to supporting the communities it serves across the Chester, Bucks, Delaware, Montgomery, Lancaster, and Philadelphia counties through ongoing community initiatives.

Key Points: 
  • EXTON, Pa., April 16, 2024 /PRNewswire/ -- Citadel Credit Union is reinforcing its dedication to supporting the communities it serves across the Chester, Bucks, Delaware, Montgomery, Lancaster, and Philadelphia counties through ongoing community initiatives.
  • Citadel employees have also been on the receiving end multiple times of VISTA Today's Millennial Superstars 40 Under 40 awards .
  • "Since joining Citadel in late 2023, I've been proud to become a part of the team's ongoing efforts to achieve growth and stability while enhancing Citadel's presence in our communities," said Bill Brown, President and CEO, Citadel Credit Union.
  • Throughout the year, Citadel continued to have strong deposit growth at 2.5% percent from the prior year.

HealthQuest Capital Welcomes Ashley McEvoy to its Advisory Board

Retrieved on: 
Martedì, Aprile 9, 2024
Worldwide, Growth, CHOP, IAB, Executive, SAN, McEvoy, Hospital, Ecosystem, Johnson & Johnson, Procter & Gamble, Children's Hospital of Philadelphia, Medtech, Pharmaceutical industry

SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- HealthQuest Capital, a private asset firm that provides capital to transformative healthcare companies, today announced the addition of Ashley McEvoy to its Industry Advisory Board (IAB). McEvoy brings over 20 years of experience from Johnson & Johnson. This appointment will enhance HealthQuest Capital as a value-add investor for its ecosystem of portfolio companies by adding another complementary industry leader to drive progress within the healthcare space.

Key Points: 
  • SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- HealthQuest Capital , a private asset firm that provides capital to transformative healthcare companies, today announced the addition of Ashley McEvoy to its Industry Advisory Board (IAB).
  • This appointment will enhance HealthQuest Capital as a value-add investor for its ecosystem of portfolio companies by adding another complementary industry leader to drive progress within the healthcare space.
  • Ashley McEvoy is the former Executive Vice President and Worldwide Chairman of Johnson & Johnson's MedTech division, Ashley oversaw a vast organization with 60,000 global employees and revenue exceeding $30 billion.
  • "The addition of Ashley McEvoy strengthens our ability to identify and support innovative healthcare companies.

Mastery Schools, Children's Hospital of Philadelphia Announce Innovative Healthcare High School to Address Local Healthcare Workforce Shortages with Support from Bloomberg Philanthropies

Retrieved on: 
Venerdì, Aprile 5, 2024
Automation, TIA, Growth, Health, CHOP, Partnership, Education, School, Knowledge, Bureau, Bloomberg L.P., Comp, Poverty, Student, Bloomberg Philanthropies, Hospital, Workforce, Dream, Children's Hospital of Philadelphia, Nursing

PHILADELPHIA, April 5, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) and Mastery Schools announced today an unprecedented partnership to design a high school that will help prepare students for well-paying careers in healthcare and address local education and healthcare talent needs. Through this initiative from Bloomberg Philanthropies, Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.

Key Points: 
  • Through this initiative from Bloomberg Philanthropies , Mastery Hardy Williams High School will be revamped to fully integrate healthcare career knowledge and job-training with a high-quality, well-rounded high school experience for students in Philadelphia, graduating students directly into high-demand healthcare jobs at CHOP with family-sustaining wages.
  • "By combining classroom learning with hands-on experience, these specialized health-care high schools will prepare students for careers with opportunities for growth and advancement.
  • Despite inflation, the labor market remains incredibly competitive, with shortages in every area from direct patient care to healthcare operations to administration.
  • Bloomberg Philanthropies' investment will support school start-up costs including personnel needs, classroom and lab renovations, and other work-based learning requirements.